Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors.

MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res. 2012 Jul 01; 72(13):3228-37.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.